Zobrazeno 1 - 10
of 294
pro vyhledávání: '"P. Soelberg Sørensen"'
Autor:
Florence Thirion, Finn Sellebjerg, Yong Fan, Liwei Lyu, Tue H. Hansen, Nicolas Pons, Florence Levenez, Benoit Quinquis, Evelina Stankevic, Helle B. Søndergaard, Thomas M. Dantoft, Casper S. Poulsen, Sofia K. Forslund, Henrik Vestergaard, Torben Hansen, Susanne Brix, Annette Oturai, Per Soelberg Sørensen, Stanislav D. Ehrlich, Oluf Pedersen
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-17 (2023)
Abstract Background Multiple sclerosis is a chronic immune-mediated disease of the brain and spinal cord resulting in physical and cognitive impairment in young adults. It is hypothesized that a disrupted bacterial and viral gut microbiota is a part
Externí odkaz:
https://doaj.org/article/92667d91f9624abab5f3c3539b861d21
Autor:
Spyridon Kontaxis, Estela Laporta, Esther Garcia, Ana Isabel Guerrero, Ana Zabalza, Martinis Matteo, Roselli Lucia, Sara Simblett, Janice Weyer, Matthew Hotopf, Vaibhav A. Narayan, Zulqarnain Rashid, Amos A. Folarin, Richard J. B. Dobson, Mathias Due Buron, Letizia Leocani, Nicholas Cummins, Srinivasan Vairavan, Gloria Dalla Costa, Melinda Magyari, Per Soelberg Sørensen, Carlos Nos, Raquel Bailón, Giancarlo Comi, the RADAR-CNS Consortium
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Objective: The aim of this study was to evaluate the association between changes in the autonomic control of cardiorespiratory system induced by walk tests and outcome measures in people with Multiple Sclerosis (pwMS).Methods: Electrocardiogram (ECG)
Externí odkaz:
https://doaj.org/article/7f1adb0735e042e49e47d84327ae9a97
Autor:
Spyridon Kontaxis, Estela Laporta, Esther Garcia, Matteo Martinis, Letizia Leocani, Lucia Roselli, Mathias Due Buron, Ana Isabel Guerrero, Ana Zabala, Nicholas Cummins, Srinivasan Vairavan, Matthew Hotopf, Richard J. B. Dobson, Vaibhav A. Narayan, Maria Libera La Porta, Gloria Dalla Costa, Melinda Magyari, Per Soelberg Sørensen, Carlos Nos, Raquel Bailon, Giancarlo Comi, on behalf of the RADAR-CNS Consortium
Publikováno v:
Sensors, Vol 23, Iss 13, p 6017 (2023)
The aim of this study was to investigate the feasibility of automatically assessing the 2-Minute Walk Distance (2MWD) for monitoring people with multiple sclerosis (pwMS). For 154 pwMS, MS-related clinical outcomes as well as the 2MWDs as evaluated b
Externí odkaz:
https://doaj.org/article/1ab1e53fe6c24dffa8cc1bdb0c30cfa6
Autor:
Isa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, Cavit Boz, Abdelkader Daif, Salam El-Koussa, Jihad Inshasi, Murat Kurtuncu, Thomas Müller, Chris Retief, Mohammad Ali Sahraian, Vahid Shaygannejad, Ilham Slassi, Karim Taha, Magd Zakaria, Per Soelberg Sørensen
Publikováno v:
Neurology and Therapy, Vol 9, Iss 1, Pp 55-66 (2020)
Abstract The majority of disease-modifying drugs (DMDs) available for the management of active relapsing–remitting multiple sclerosis (RMS) depend on continuous drug intake for maintained efficacy, with escalation to a more active drug when an unac
Externí odkaz:
https://doaj.org/article/d3719307184542cdada0b1a811335e4c
Autor:
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: Gaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccina
Externí odkaz:
https://doaj.org/article/e93636f89bdc48f2b139203c90ec96a4
Autor:
Jan Hillert, Melinda Magyari, Per Soelberg Sørensen, Helmut Butzkueven, Anneke Van Der Welt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Fabio Pellegrini, Robert Hyde, Leszek Stawiarz, Ali Manouchehrinia, Tim Spelman
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Although over a dozen disease modifying treatments (DMTs) are available for relapsing forms of multiple sclerosis (MS), treatment interruption, switching and discontinuation are common challenges. The objective of this study was to descri
Externí odkaz:
https://doaj.org/article/7b575aa03c2940f0b421f060c9883e06
Autor:
Per Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, Xavier Montalban, Daniel Selchen, Patrick Vermersch, Heinz Wiendl, Bassem Yamout, Hashem Salloukh, Peter Rieckmann
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians’ questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswere
Externí odkaz:
https://doaj.org/article/6c3be6a63f0c4acb8686a118c7181c02
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Medical Journal Neurology, Vol 4, Iss 1, Pp 36-44 (2016)
Brain volume loss (BVL) progresses more rapidly in patients with multiple sclerosis (MS) than in healthy individuals, and brain atrophy begins early in the course of the disease. The objective of this symposium was to emphasise the importance of care
Externí odkaz:
https://doaj.org/article/87d5153c102e43039b58cf506ce4fd7f
Autor:
Jenny Link, Ryan Ramanujam, Michael Auer, Malin Ryner, Signe Hässler, Delphine Bachelet, Cyprien Mbogning, Clemens Warnke, Dorothea Buck, Poul Erik Hyldgaard Jensen, Claudia Sievers, Kathleen Ingenhoven, Nicolas Fissolo, Raija Lindberg, Verena Grummel, Naoimh Donnellan, Manuel Comabella, Xavier Montalban, Bernd Kieseier, Per Soelberg Sørensen, Hans-Peter Hartung, Tobias Derfuss, Andy Lawton, Dan Sikkema, Marc Pallardy, Bernhard Hemmer, Florian Deisenhammer, Philippe Broët, Pierre Dönnes, Julie Davidson, Anna Fogdell-Hahn, ABIRISK Consortium
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0170395 (2017)
Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in several European countries. ADA data generated in Europe during the more than 10 years of ADA monito
Externí odkaz:
https://doaj.org/article/c098f1a316884e999aa568f4cc0fc10e